AT MARKET ISSUANCE SALES AGREEMENTNovavax Inc • December 31st, 2018 • Biological products, (no disgnostic substances) • New York
Company FiledDecember 31st, 2018 Industry Jurisdiction
AT MARKET ISSUANCE SALES AGREEMENTNovavax Inc • December 31st, 2018 • Biological products, (no disgnostic substances) • New York
Company FiledDecember 31st, 2018 Industry Jurisdiction